Veracyte, Inc. VCYT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 318.41% | 334.72% | 166.31% | 174.89% | 427.11% |
| Total Depreciation and Amortization | -3.69% | -9.36% | -7.52% | -8.71% | -4.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -57.12% | -28.48% | 22.73% | 4.90% | -0.53% |
| Change in Net Operating Assets | 71.45% | 99.62% | 103.76% | 89.02% | 25.92% |
| Cash from Operations | 60.63% | 90.88% | 85.81% | 81.51% | 63.70% |
| Capital Expenditure | -18.90% | -30.62% | 1.39% | 14.26% | -4.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -147.36% | 15.67% | 28.31% | 106.63% | -- |
| Cash from Investing | -394.49% | 8.99% | 23.09% | 83.64% | -1,150.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 30.12% | -0.22% | -30.72% | -29.57% | -25.21% |
| Repurchase of Common Stock | -17.87% | -16.47% | -12.40% | -72.86% | -112.26% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 63.67% | 126.59% | -509.92% | -186.09% | -185.33% |
| Foreign Exchange rate Adjustments | -129.41% | -103.06% | 342.56% | 269.58% | 11.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -375.23% | 604.95% | 442.27% | 430.43% | -41.45% |